Oral dose packaging sales will strengthen through 2036, anchored by disposable formats at 64.3% of the dose type segment in 2026. The market was valued at USD 146.50 billion in 2025 and is expected to be worth USD 816.97 billion by 2036, creating an incremental opportunity of USD 645.70 billion.